Accredited InvestorsEmployee ShareholdersInstitutionsPrivate Companies Who We Serve Trading and Investing Data Solutions Private Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Browse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunities​Forge DataAnalyze private markets via Forge’s intuitive web application​Forge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All Insights Private Market Reports Market Insights Buying and Selling Pre-IPO​ All Reports​Private Market UpdatesForge Investment OutlookStartup News and Trends​Private Market Data and Analytics​Tech IPO Calendar for 2024​Private Market Explained​Buying Pre-IPO Shares​Selling Pre-IPO SharesGlossaryVideosFAQsInsights About UsLeadershipInvestor RelationsPeople & CultureCareers About
Log InSign Up
Who We Serve
Solutions
Insights
About
Who We Serve
Solutions
Trading and Investing
Institutional Trading
Individual Investing
Data Solutions
Private Asset Custody
Self-Directed IRA
Insights
Private Market Reports
Market Insights
Buying and Selling Pre-IPO​
About
Log In
Sign Up
Secondary Marketplace / Explore Private Companies / Neurona Therapeutics IPO

Neurona Therapeutics IPO

www.neuronatherapeutics.comHealthcare / BioTech & Pharma

Neurona Therapeutics is a company that strives to develop clinical-stage biotherapeutic treatments for neurological disorders with a focus on advancing regenerative cell therapy candidates. The company researches allogeneic therapies that come from stem cells harvested from donors. Neurona's proprietary therapy NRTX-1001 aims to reverse the effects of Alzheimer’s disease and other nervous system disorders. Neurona Therapeutics was founded by Arnold Kriegstein and Cory R. Nicholasin in 2008 and is headquartered in San Francisco, CA.

Buy or sell Neurona Therapeutics stock Learn more about Neurona Therapeutics stock
Register for Details

For more details on financing and valuation for Neurona Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Neurona Therapeutics

Forge green plus iconForge green minus icon

Is Neurona Therapeutics a publicly traded company?

Neurona Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

Will Neurona Therapeutics go IPO?

Neurona Therapeutics has not yet filed for an IPO. However, it's important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or through mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

Forge green plus iconForge green minus icon

What is Neurona Therapeutics's IPO price?

The IPO price for Neurona Therapeutics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Neurona Therapeutics pre-IPO?

Neurona Therapeutics is privately held company and is not publicly traded, therefor investing in Neurona Therapeutics pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.

Forge green plus iconForge green minus icon

What is the value of my Neurona Therapeutics shares?

To determine the value of your Neurona Therapeutics shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your Neurona Therapeutics shares. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Can you sell Neurona Therapeutics before it goes public?

Yes, you can seek to sell shares in Neurona Therapeutics while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

Forge green plus iconForge green minus icon

What is Neurona Therapeutics's funding to date?

Neurona Therapeutics has raised $240.58MM to date.
Forge green plus iconForge green minus icon

When was Neurona Therapeutics founded?

Neurona Therapeutics was founded in 2008.

Who are Neurona Therapeutics's major investors?

Viking Global Investors
Euclidean Capital
Ironfire Ventures
Cormorant Asset Management
Spur Capital Partners
National Institutes of Health
The Column Group
SymBiosis Capital Management
Ysios Capital
UC Investments
LYFE Capital
Schroders Capital
UCB Ventures
California Institute for Regenerative Medicine
SC Launch
Topspin Consumer Partners
Sphera Funds Management
Harvard University Endowment
Berkeley Frontier Fund
Willett Advisors

Neurona Therapeutics funding rounds and last known valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
2/8/2024

Series E

 $120MM raised $XXX.XX $XXX.XX
3/19/2021

Series D

 $72.01MM raised $XXX.XX $XXX.XX
11/18/2019

Series C

 $15.03MM raised $XXX.XX $XXX.XX
2/8/2018

Series B

 $10.04MM raised $XXX.XX $XXX.XX
12/1/2015

Series A

 $23.5MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Private companies exploring an IPO

Cerebras
Sector
Technology Hardware / Computing hardware
Last Round Est. Valuation
$2.87B
CoreWeave
Sector
Enterprise Software / Data Intelligence
Last Round Est. Valuation
$19B
Liquid Death
Sector
FoodTech / Food Products & Services
Last Round Est. Valuation
$1.4B
Vuori
Sector
Consumer & Lifestyle / Clothing, Fashion, Beauty & Apparel
Last Round Est. Valuation
$213.97MM
Cohesity
Sector
Enterprise Software / Data Management/​Storage
Last Round Est. Valuation
$3.4B
Klarna
Sector
FinTech / Lending
Last Round Est. Valuation
$5.41B
Chime
Sector
FinTech / Digital Banking
Last Round Est. Valuation
$24.93B
SKIMS
Sector
Consumer & Lifestyle / Clothing, Fashion, Beauty & Apparel
Last Round Est. Valuation
$4B
See the IPO Calendar
Trending Companies

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.